Bohui Ruijin

Beijing, China Founded: 2016 • Age: 10 yrs
Biomaterials and surgical implants are provided for regenerative medicine applications.
Annual revenue - Latest available
Total funding $12.8M 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Bohui Ruijin

Bohui Ruijin is a company based in Beijing (China) founded in 2016 by Zhao Bo and Zhang Jinhui. Bohui Ruijin has raised $12.82 million across 2 funding rounds from investors including Proxima Ventures and Medfine Capital. Bohui Ruijin operates in a competitive market with competitors including NeuWave, KLOwen, Aibo Medical, Spectrohm and Panorama Eyecare, among others.

  • Headquarter Beijing, China
  • Founders Zhao Bo, Zhang Jinhui
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $12.82 M (USD)

    in 2 rounds

  • Latest Funding Round
    $9.36 M (USD), Series B

    Dec 01, 2016

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Bohui Ruijin

Bohui Ruijin has successfully raised a total of $12.82M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $9.36 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $9.4M
  • First Round

    (01 Jun 2016)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2016 Amount Series B - Bohui Ruijin Valuation Proxima Ventures
Jun, 2016 Amount Series A - Bohui Ruijin Valuation

investors

Investors in Bohui Ruijin

Bohui Ruijin has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Proxima Ventures and Medfine Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location

Investments & Acquisitions by Bohui Ruijin

Investments

Financial Statements - Bohui Ruijin

Bohui Ruijin Comparisons

+
Add Comparison
Available on Premium

Competitors of Bohui Ruijin

Bohui Ruijin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuWave, KLOwen, Aibo Medical, Spectrohm and Panorama Eyecare, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Microwave ablation systems for soft tissue and cancer are developed.
domain founded_year HQ Location
Digital tools for orthodontists are provided by KLOwen.
domain founded_year HQ Location
Vascular interventional surgery robot systems are developed by the company.
domain founded_year HQ Location
Provider of radio-frequency internal imaging solutions for medical, security, and non-destructive evaluation
domain founded_year HQ Location
Physician-led management services for eye care professionals are provided.
domain founded_year HQ Location
Healthcare technology management services and equipment are provided.

Latest news on Bohui Ruijin

Frequently Asked Questions about Bohui Ruijin

Bohui Ruijin was founded in 2016.

Bohui Ruijin is headquartered in Beijing, China.

Li Xuejun is the current CEO of Bohui Ruijin.

Bohui Ruijin is a funded company, having raised a total of $12.82M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.46M, raised on Jun 01, 2016.

Bohui Ruijin was established in 2016 in Beijing, China, within the regenerative medicine sector. Surgical repair implants and minimally invasive instruments are developed for abdominal, gastrointestinal, neurosurgical, maxillofacial, orthopedic, thoracic, and otolaryngological procedures. Implanted regenerative products, such as bio-twisting patches, anastomotic reinforcements, biological dura mater, anal fistula treatments, bio-muscle repair matrices, and bio-ear biopsies, are included in the portfolio alongside specialized surgical tools.

Bohui Ruijin's top competitors include KLOwen, Spectrohm and NeuWave.

Bohui Ruijin has 2 investors. Key investors include Proxima Ventures, and Medfine Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available